Trempe Lab

Trempe Lab

Share

This is the lab of Jean-François Trempe, associate professor in the department of Pharmacology & Therapeutics at McGill University. Our goal is to understand how proteins implicated in recessive forms of Parkinson's disease (PD) normally protect neurons, and how they are inactivated in PD. Our approach consists of elucidating their structures using a wide-range of techniques such as X-ray crystall

Mechanism of PINK1 activation by autophosphorylation and insights into assembly on the TOM complex 01/13/2022

We are back on Facebook! Here is our latest story on the mechanism of PINK1 activation via autophosphorylation. Congratulations to PhD student Shafqat Rasool, with critical contribution from postdoc Simon Veyron and collaborators from the Lukacs and Fon labs. Here is a little story about it.

This project stemmed from the observation that PINK1 autophosphorylates upon accumulating on damaged mitochondria. This step is important for efficient Parkin recruitment. Later on, we and others showed that PINK1 autophosphorylates at an invariant serine (S228 in human), and that this step was critical for binding its substrate ubiquitin. Now, folks who know a thing or two about kinases would see that this is a very unusual autophos site. We knew it was in "trans", i.e. one PINK1 molecule with ATP phosphorylates Ser228 in another PINK1 molecule. But the mechanism was unclear.

To solve that problem, we engineered an insect PINK1 variant with solubilizing mutations and co-expressed with a phosphatase to make the completely dephosphorylated protein in vitro. And it crystallized! Crystal contacts revealed in all its glory the autophosphorylation dimer, with the target serine from one molecule reaching out nicely into the active site of the other. PINK1 possesses three unique "insertions" compared to other kinases. We knew that "Insert-3" was critical for Ub binding, but the new dimer structure revealed that "insert-2" is critical for mediating autophosphorylation.

Now, the structure had more to offer. Just upstream of the "canonical" kinase domain is an N-term helix that binds to the C-term extension. The helix harbours Parkinson's mutations, like C125G and A126P, but how these mutations impair PINK1 was unclear. We find that the NT helix and CTE form a module that is essential for PINK1 to form a ~750 kDa complex with the translocase of the outer membrane on mitos. Mutations that disrupt the NT helix basically disrupts PINK1's ability to form that complex. We hope this work will help elucidate how PINK1 acts as a "damage sensor" by integrating and relaying stress signals. There is still much to be learned, especially regarding its intriguing mitochondrial targeting sequences and interactions with the import machinery.

Mechanism of PINK1 activation by autophosphorylation and insights into assembly on the TOM complex Rasool et al. solved crystal structures of the cytosolic domain of PINK1, revealing how dimerization allows for trans autophosphorylation at the conserved Ser205 site. The NT and CTE regions flanking the kinase domain form a module that is essential for PINK1 stabilization on the TOM complex upon m...

Photos from CRBS McGill's post 04/17/2020

Great talks, well done.

Ddi1 is a ubiquitin-dependent protease 03/25/2020

Well, that's cool. We've published the structure of Ddi1 back in 2016. I'm intrigued as to how the HDD domain contributes to polyubiquitin-chain recognition, structurally.

Ddi1 is a ubiquitin-dependent protease Many proteins in the cell are tagged with a polyubiquitin chain, which serves as a recognition signal for degradation by the proteasome. Some tagged substrates bind directly to the proteasome, but others are delivered through shuttling factors. Yeast Ddi1 and its homologs in other eukaryotic cells h...

Want your university to be the top-listed University in Montreal?
Click here to claim your Sponsored Listing.

Category

Address


3655 Promenade Sir William Osler
Montreal, QC
H3G1Y6